Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: GSK profit up; Vodafone growth slows; US Fed ahead

Wed, 01st Feb 2023 09:13

(Alliance News) - Stock prices in London opened higher on Wednesday, as investors expect to see the US central bank continue to slow the pace of its interest rate hikes.

The FTSE 100 index opened up 23.53 points, 0.3%, at 7,795.23. The FTSE 250 was up 129.18 points, 0.7%, at 19,982.63, and the AIM All-Share was up 3.71 points, 0.4%, at 871.53.

The Cboe UK 100 was up 0.3% at 779.52, the Cboe UK 250 up 0.7% at 17,443.15, and the Cboe Small Companies up 0.1% at 14,093.42.

The Federal Reserve will kick off the week's interest rate announcements on Wednesday at around 1900 GMT. The Bank of England and the European Central Bank will then have their turn on Thursday.

Markets are expecting a 25 basis point hike from the US central bank, slowing from a 50-point hike in December and 75-point hikes before that. In contrast, 50-point hikes are expected from the BoE and the ECB.

In the US on Tuesday, Wall Street ended higher, with the Dow Jones Industrial Average ending up 1.1%, the S&P 500 up 1.5% and the Nasdaq Composite up 1.7%.

"US markets have also got a new lease of life in the last two weeks with the best start to the year for the S&P 500 since 2019. The Nasdaq 100 has also enjoyed a stellar second half of the month gaining 10.6%, with yesterday’s strong finish set to translate into a positive European open," said CMC Markets Chief Market Analyst Michael Hewson.

"Judging by these January gains it would appear that US investors have made up their minds that the Fed is about to hit the pause button today, as it gets set to raise rates by an expected 25bps. This would push the Fed Funds rate to 4.5% to 4.75%, which is still well below what several policymakers have insisted consistently over the past few months is somewhere between 5% and 5.25%."

In the UK, house prices fell on a monthly basis for the fifth month in a row, according to figures from Nationwide on Wednesday.

In January, house prices fell by 0.6% on a monthly basis, worsening after a fall of 0.3% in December. On an annual basis, house prices rose 1.1% in January, slowing from a 2.8% increase in December.

The average UK house price stood at GBP258,297, down from GBP262,068 in December. House prices are now 3.2% below August's peak, Nationwide said.

"However, there are some encouraging signs that mortgage rates are normalising, but it is too early to tell whether activity in the housing market has started to recover. The fall in house purchase approvals in December reported by the Bank of England largely reflects the sharp decline in mortgage applications following the mini-Budget," said Nationwide Chief Economist Robert Gardner.

The Irish factory sector stabilised at the start of the year, edging into slight expansion as order book volumes stabilised, according to survey results on Wednesday.

The AIB manufacturing purchasing managers' index rose to 50.1 points from 48.7 in December.

Being above the 50-point neutral line, the score represented slight growth for the Irish manufacturing sector and was the highest in three months, breaking a two-month string of declines, according S&P Global, which conducts the monthly survey.

"Encouragingly, the Irish data showed the smallest fall in new orders since they first began to decline in June last year, though demand remains muted," commented AIB Chief Economist Oliver Mangan. "The pace of contraction in output also eased considerably, with just a small fall in the month."

The UK manufacturing PMI is due at 0930 GMT.

In European equities on Wednesday, both the CAC 40 in Paris and DAX 40 in Frankfurt were up 0.1%.

Sterling was quoted at USD1.2319 early Wednesday, lower than USD1.2375 at the London equities close on Tuesday.

The euro traded at USD1.0880 early Wednesday, higher than USD1.0861 late Tuesday. Against the yen, the dollar was quoted at JPY130.09, down versus JPY130.17.

In the FTSE 100, GSK gained 0.4%.

The drug maker posted revenue of GBP29.32 billion in 2022, up from GBP24.70 billion a year earlier. Pretax profit climbed in the year to GBP5.63 billion from GBP3.60 billion in 2021. The 2021 figures exclude the consumer healthcare arm.

The company declared a 13.75 pence dividend for the fourth quarter of 2022, bringing the annual dividend to 61.25p. In 2021, before the spin-off of consumer arm Haleon, GSK declared a 100p full-year dividend.

Looking ahead, GSK said it expected 2023 turnover to increase by between 6% and 8%, adjusted operating profit to rise by between 10% and 12%, and earnings per share to be up by between 12% and 15%. The expected dividend for 2023 is 56.5p per share.

Vodafone lost 3.2% in early trade, making it the FTSE 100's worst performer.

Vodafone said "we can do better", as it reported that growth slowed in the third-quarter.

On an organic basis, service revenue rose 1.8% year-on-year during the quarter ended December 31. It had risen 2.5% yearly in the second quarter.

On a reported basis, service revenue was 1.3% lower on-year at EUR9.52 billion from EUR9.65 billion. Total revenue amounted to EUR11.64 billion, down 0.4% from EUR11.68 billion a year earlier, but up 2.7% on an organic basis.

Vodafone backed yearly guidance, expected adjusted earnings before interest, tax, depreciation, amortisation and after leases between EUR15.0 billion and EUR15.2 billion. At best, that would be around the EUR15.21 billion achieved in financial 2022.

Vodafone also expects adjusted free cashflow of around EUR5.1 billion, which would be down around 6.2% from EUR5.44 billion the year prior.

"Although we're continuing to target our financial guidance for the year, the recent decline in revenue in Europe shows we can do better. We need to do more for our customers by delivering quality connectivity in an easy way. We've already taken action, including simplifying our structure to give local markets full autonomy and accountability to make the best commercial decisions for their customers," Chief Executive Margherita Della Valle said.

In the FTSE 250 index, FDM Group gained 1.5%, after the IT-focused professional services provider said it expects 2022 results in line with expectations.

FDM said it performed "well" in 2022, with each of its primary regions showing year-on-year growth in Consultants deployed, and a particularly strong performance in North America.

It noted that it expects to report revenue for the year of GBP330 million, up 23% year-on-year from GBP267 million. It also ended the year with 4,905 consultants placed with clients, up 22% annually from 4,033.

Looking ahead, CEO Rod Flavell said: "As we enter 2023 there remains a high degree of macro-economic and political uncertainty in some of the regions where we operate. However, across the group we continue to see healthy levels of client engagement and activity."

FDM will release its full annual results on March 15.

On AIM, Orcadian Energy lost 22% to 11.73 pence.

The company said it plans to raise GBP500,000 from a placing of 5.0 million shares. The placing shares are priced at 10p per share, which represents a discount of 33% to the closing price of 15p per share on January 31.

Orcadian said the proceeds will help fund licence fees and progress its field development plan.

Stocks in Asia rose on Wednesday, despite some disappointing data about China and Japan's manufacturing sectors.

In Tokyo, the Nikkei 225 index closed up 0.1%. The Shanghai Composite closed up 0.9%, and the Hang Seng index in Hong Kong was up 1.1%. The S&P/ASX 200 in Sydney closed up 0.3%.

China's manufacturing sector continued to decline for the sixth month in a row in January, according to new data.

The Caixin China manufacturing PMI rose to 49.2, from 49.0 in December. Coming in below the 50.0 no-change mark, it shows the sector remains in contraction, though the rate of deterioration eased marginally.

"Both manufacturing supply and demand continued to shrink last month, as Covid infections remained high. Output and total new orders shrank for the fifth and sixth straight months, respectively, but the contraction was milder than in December. Due to mounting recession risks overseas, external demand remained weak, with the reading for new export orders also contracting for the sixth consecutive month," said Wang Zhe, Caixin senior economist.

Japan's manufacturing sector also stayed in contraction territory at the beginning of 2022. The au Jibun Bank manufacturing PMI was unchanged from the previous month at 48.9 in January, suggesting an "overall stabilisation of manufacturing business conditions".

Gold was quoted at USD1,924.43 an ounce early Wednesday, lower than USD1,927.04 on Tuesday.

Brent oil was trading at USD85.88 a barrel early Wednesday, higher than USD85.27 late Tuesday. An OPEC meeting is scheduled for Wednesday.

In addition to the Fed's interest rate announcement, the economic calendar on Wednesday has a slew of PMI readings and an inflation reading for the eurozone at 1000 GMT.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.